Stents (grafting) should be the primary treatment for symptomatic superficial femoral artery disease.
Ansel
Gary M
GM
Riverside Methodist Hospital, MidOHio Cardiology and Vascular Consultants, Columbus, Ohio, USA. gansel@mocvc.com
D000497:Alloys; D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000266:history; D001157:Arterial Occlusive Diseases / Q000601:surgery / Q000628:therapy*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000266:history; D005263:Femoral Artery / Q000601:surgery*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D018579:Patient Selection; D011138:Polytetrafluoroethylene; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D012720:Severity of Illness Index; D015607:Stents / Q000009:adverse effects / Q000266:history; D016896:Treatment Outcome
D000497:Alloys; C013616:nitinol; D011138:Polytetrafluoroethylene